S.V. SHTAIMETS¹, N.G. ZHUKOVA², I.A. ZHUKOVA², A.E. AGASHEVA², D.A. NOVOTNYY³

 ¹Municipal Clinic № 3, Omsk

²Siberian State Medical University, Tomsk

³Municipal Clinical Polycllinic № 1, Novosibirsk

Contact details:

Shtaimets S.V. — Head of the Day Care Department for Neurological Diseases

Address: 26a Williams St., Russian Federation, Omsk, 644060, tel.: +7-904-321-59-76, e-mail: [email protected],

Standardization of medical and diagnostic care is one of the most urgent problems of modern clinical medicine. However, whether the course of Parkinson’s disease (PD) depends on compliance or deviation from the established regulations remains unclear.

The purpose. To evaluate the effectiveness of medical care provided to patients with PD in accordance with the standard and clinical recommendations, in comparison with patients who were treated with violations; to study the impact on the course and progression of the disease of non-compliance with certain provisions of the standard and clinical recommendations.

Material and methods. The analysis of 7264 examinations of the quality of medical care of 1754 patients with PD during 60 months was carried out.

Results. Defects in the provision of medical care that affected the progression of the disease, as well as the formation of social and household maladaptation (disability) were identified. There were deviations from the standards in the management of patients which did not have a significant impact on PD.

Conclusions. Medical care provided according to the standards of management of PD patients approved in the Russian Federation does not affect the course of the disease, but helps to postpone the period of disability. With a high confidence level, the disease progression and reduction of the degree of social and professional adaptation are influenced by the defects in complaints and anamnesis collection, as well as not timely administration of medicaments containing levodopa, against the background of, most likely, non-compliance with all clinical recommendations and standards for PD patients.

Keywords: Parkinson’s disease, quality of medical care, medical care standards, medical care defects, progression. 

REFERENCES

1.            Reabilitatsiya pri bolezni Parkinsona i sindrome parkinsonizma pri drugikh zabolevaniyakh. Klinicheskie rekomendatsii [Rehabilitation in Parkinson’s disease and Parkinson’s syndrome in other diseases. Clinical guidelines]. Natsional’noe obshchestvo po izucheniyu bolezni Parkinsona i rasstroystv dvizheniy, Soyuz reabilitologov Rossii, 2018, available at: https://rehabrus.ru/Docs/2019/rekomendacii-po-reabilitacii-parkinsonizma-smolenceva.pdf (accessed on: 3.09.2020).

2.            Shprakh V.V., Sayutina S.B. Problems of standardization of therapeutic and diagnostic care in Parkinson’s disease. Sibirskiy meditsinskiy zhurnal, 2012, no. 6, pp. 95–97 (in Russ.).

3.            Bereznikov A.V., Berseneva E.A., Shkitin S.O. Ekspertiza kachestva meditsinskoy pomoshchi [Examination of the quality of medical care]. Moscow: Svetlitsa, 2019. 176 p.

4.            Shkitin S.O., Berseneva E.A., Bereznikov A.V. Optimization of drug therapy in therapeutic departments of a multidisciplinary hospital based on the introduction of procedures and standards of medical care. Vestnik sovremennoy klinicheskoy meditsiny, 2018, no. 3, pp. 65–70 (in Russ.).

5.            Ryzhakov A.D. et al. Management of the quality of medical care at the regional level: the use of thematic planned quality examinations. Vestnik Roszdravnadzora, 2015, no. 2, pp. 60–64 (in Russ.).

6. Kharisov A.M. State normative acts and local acts of a medical organization as an element of building a system of internal quality control of doctors’ training. Obshchestvennoe zdorov’e i zdravookhranenie, 2019, no. 4 (64), pp. 59–63 (in Russ.).

7.            Shindryaeva N.N. The quality of medical care for patients with Parkinson’s disease in Nizhny Novgorod. Izvestiya vysshikh uchebnykh zavedeniy. Povolzhskiy region. Meditsinskie nauki, 2012, no. 1 (21), pp. 124–129 (in Russ.).

8.            Murashko M.A. et al. Unified approaches to the examination of the quality of medical care. Vestnik Roszdravnadzora, 2016, no. 1, pp. 5–9 (in Russ.).

9.            Ma S.Y. et al. Dopamine transporter-immunoreactive neurons decrease with age in the human substantianigra. J. Comp. Neurol, 1999, vol. 409 (1), pp. 25–37.

10.          Morrish P.K., Sawle G.V., Brooks D.J. An 18F-dopa PET and clinical study of the rate of progression in Parkinson’s disease. Brain, 1996, vol. 119, pp. 223–591.

11.          Levin O.S. On the rational use of levodopa in Parkinson’s disease. Trudnyy patsient, 2006, vol. 4, no. 7, pp. 59–65 (in Russ.).